Rainer Stähler Reflects on The Year 2025 for DHG
Rainer Stähler, Process and Transformation Manager at Matrix42, reposted from German Hemophilia Society on LinkedIn:
”As I leaf through the 105 pages of this issue of Haemophilia Journal, I can feel the energy of the DHG.
At the same time, the current issue reflects a successful and eventful year.
When I sit back and look back, I see all the wonderful moments, valuable encounters, and shared experiences.
I see not only dates and events, but above all people, people who are committed to each other, who share their knowledge and thus strengthen the DHG community, which is indispensable for all of us.
This year shows me once again tha DHG is much more than an association.
It is a network, a family, and a place where those affected and their families can find answers, support, and hope.
I am proud that DHG has been a reliable point of contact for people with hemophilia, von Willebrand disease, and other bleeding disorders for almost 70 years.
Our motto, “Blood connects us all,” is more than just a phrase for us; it is a living reality.
We create spaces for people to meet, exchange ideas, and share knowledge.
That is our foundation, and it should make us proud.”
Quoting Deutsche Hämophiliegesellschaft (German Hemophilia Society)‘s post:
”Just in time for Christmas: the new issue of Hämophilie-Blätter is here!
The latest issue of our member magazine, Hämophilie-Blätter, will be arriving in our members’ mailboxes in the coming days.
We are also happy to send you the magazine as a PDF file.
Just send us a quick email at: [email protected].
Hämophilie-Blätter is published twice a year and provides information not only about past events and online seminars as well as the latest news from DHG, but also interesting news about coagulation disorders and social law issues.
If you are not yet a member but are interested in joining, simply visit our website www.dhg.de and discover the benefits of membership.
Click here and stay informed!”
Stay updated with Hemostasis Today.
-
Jul 14, 2026, 19:35Daratumumab in Difficult-to-Treat iTTP: Updated Results from the International DarTTP Study
-
Jul 14, 2026, 17:1610 Posts Not To Miss from ISTH 2026, Part 3
-
Jul 14, 2026, 15:27Dianne E Van Der Wal: Celebrating Scientific Contributions at ISTH 2026
-
Jul 14, 2026, 15:13Alfonso Tafur: RIETE Registry Analysis Supports More Equitable Approaches to VTE Care
-
Jul 14, 2026, 15:03Heghine Khachatryan: Phase III Trial Results Support BAFF-R Inhibition in Corticosteroid-Refractory ITP
-
Jul 14, 2026, 14:51Nathan Connell: ISTH 2026 Highlights the Power of Lifelong Collaboration
-
Jul 14, 2026, 14:42Wolfgang Miesbach: VOYAGER1 Highlights Progress Toward Injection-Free Care in Hemophilia A
-
Jul 14, 2026, 12:08Elvira Grandone: Finding the Right LMWH Dose for Pregnant Patients Suffering From DVT
-
Jul 14, 2026, 12:05Eloïse Laouenan: From Washington to Paris – Join GETBO at ISTH 2026